<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Progressive Supranuclear Palsy - Interactive Management Algorithm</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            background: linear-gradient(135deg, #f5f7fa 0%, #e9ecef 100%);
            color: #2c3e50;
            line-height: 1.6;
            overflow-x: hidden;
        }

        .container {
            display: flex;
            max-width: 1400px;
            margin: 0 auto;
            position: relative;
        }

        /* Progress Sidebar */
        .progress-sidebar {
            position: fixed;
            left: 0;
            top: 0;
            height: 100vh;
            width: 250px;
            background: white;
            box-shadow: 2px 0 10px rgba(0,0,0,0.1);
            z-index: 1000;
            padding: 2rem 1rem;
            transition: transform 0.3s ease;
        }

        .progress-sidebar h3 {
            font-size: 1.1rem;
            margin-bottom: 1.5rem;
            color: #495057;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .progress-item {
            display: flex;
            align-items: center;
            padding: 0.75rem;
            margin-bottom: 0.5rem;
            border-radius: 8px;
            cursor: pointer;
            transition: all 0.3s ease;
            position: relative;
        }

        .progress-item:hover {
            background: rgba(0,0,0,0.05);
            transform: translateX(5px);
        }

        .progress-item.active {
            background: linear-gradient(135deg, var(--card-color) 0%, var(--card-color-light) 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(0,0,0,0.15);
        }

        .progress-icon {
            width: 32px;
            height: 32px;
            margin-right: 12px;
            background: rgba(255,255,255,0.2);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1rem;
        }

        .progress-line {
            position: absolute;
            left: 16px;
            top: 60px;
            bottom: 20px;
            width: 2px;
            background: linear-gradient(to bottom, #1976d2, #388e3c, #f57c00);
            z-index: -1;
        }

        /* Main Content */
        .content {
            flex: 1;
            margin-left: 250px;
            padding: 2rem;
        }

        header {
            text-align: center;
            margin-bottom: 3rem;
            padding: 2rem;
            background: white;
            border-radius: 12px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.08);
        }

        header h1 {
            font-size: 2.5rem;
            color: #1976d2;
            margin-bottom: 0.5rem;
        }

        header p {
            color: #6c757d;
            font-size: 1.1rem;
        }

        /* Card Base Styles */
        .card {
            background: white;
            border-radius: 16px;
            margin-bottom: 2rem;
            box-shadow: 0 6px 25px rgba(0,0,0,0.1);
            overflow: hidden;
            transition: all 0.4s cubic-bezier(0.175, 0.885, 0.32, 1.275);
            position: relative;
        }

        .card:hover {
            transform: translateY(-8px) scale(1.02);
            box-shadow: 0 12px 35px rgba(0,0,0,0.15);
        }

        .card-header {
            padding: 1.5rem 2rem;
            color: white;
            display: flex;
            align-items: center;
            justify-content: space-between;
            cursor: pointer;
            position: relative;
            overflow: hidden;
        }

        .card-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.15) 0%, transparent 70%);
            transform: rotate(45deg);
            transition: all 0.5s ease;
        }

        .card:hover .card-header::before {
            top: -100%;
            right: -100%;
        }

        .card-title {
            display: flex;
            align-items: center;
            font-size: 1.5rem;
            font-weight: 600;
        }

        .card-icon {
            width: 48px;
            height: 48px;
            background: rgba(255,255,255,0.2);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-right: 1rem;
            font-size: 1.5rem;
        }

        .expand-icon {
            font-size: 1.5rem;
            transition: transform 0.3s ease;
        }

        .card.expanded .expand-icon {
            transform: rotate(180deg);
        }

        .card-body {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease;
        }

        .card.expanded .card-body {
            max-height: 3000px;
        }

        .card-content {
            padding: 2rem;
        }

        /* Card Colors */
        .assessment-card {
            --card-color: #1976d2;
            --card-color-light: #42a5f5;
        }

        .assessment-card .card-header {
            background: linear-gradient(135deg, var(--card-color) 0%, var(--card-color-light) 100%);
        }

        .diagnosis-card {
            --card-color: #7b1fa2;
            --card-color-light: #ab47bc;
        }

        .diagnosis-card .card-header {
            background: linear-gradient(135deg, var(--card-color) 0%, var(--card-color-light) 100%);
        }

        .treatment-card {
            --card-color: #388e3c;
            --card-color-light: #66bb6a;
        }

        .treatment-card .card-header {
            background: linear-gradient(135deg, var(--card-color) 0%, var(--card-color-light) 100%);
        }

        .followup-card {
            --card-color: #f57c00;
            --card-color-light: #ffb74d;
        }

        .followup-card .card-header {
            background: linear-gradient(135deg, var(--card-color) 0%, var(--card-color-light) 100%);
        }

        /* Content Styles */
        .section {
            margin-bottom: 2rem;
        }

        .section h3 {
            color: var(--card-color);
            margin-bottom: 1rem;
            font-size: 1.3rem;
            padding-bottom: 0.5rem;
            border-bottom: 2px solid rgba(0,0,0,0.1);
        }

        .section ul {
            list-style: none;
            padding-left: 0;
        }

        .section li {
            padding: 0.75rem 0;
            padding-left: 2rem;
            position: relative;
            border-bottom: 1px solid rgba(0,0,0,0.05);
        }

        .section li::before {
            content: '‚ñ∏';
            position: absolute;
            left: 0;
            color: var(--card-color);
            font-weight: bold;
        }

        .badge {
            display: inline-block;
            padding: 0.25rem 0.75rem;
            border-radius: 20px;
            font-size: 0.8rem;
            font-weight: 600;
            margin-left: 0.5rem;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .badge-urgent {
            background: #ef5350;
            color: white;
        }

        .badge-caution {
            background: #ffb74d;
            color: #2c3e50;
        }

        .badge-stable {
            background: #66bb6a;
            color: white;
        }

        .table-container {
            overflow-x: auto;
            margin: 1rem 0;
            border-radius: 8px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
        }

        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
        }

        th, td {
            padding: 1rem;
            text-align: left;
            border-bottom: 1px solid #e0e0e0;
        }

        th {
            background: var(--card-color);
            color: white;
            font-weight: 600;
        }

        tr:hover {
            background: rgba(0,0,0,0.03);
        }

        .highlight-box {
            background: rgba(25, 118, 210, 0.1);
            border-left: 4px solid #1976d2;
            padding: 1rem;
            margin: 1rem 0;
            border-radius: 4px;
        }

        .warning-box {
            background: rgba(239, 83, 80, 0.1);
            border-left: 4px solid #ef5350;
            padding: 1rem;
            margin: 1rem 0;
            border-radius: 4px;
        }

        .info-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 1rem;
            margin: 1rem 0;
        }

        .info-item {
            background: rgba(0,0,0,0.03);
            padding: 1rem;
            border-radius: 8px;
            border: 1px solid rgba(0,0,0,0.1);
        }

        .info-item h4 {
            color: var(--card-color);
            margin-bottom: 0.5rem;
        }

        /* Responsive Design */
        @media (max-width: 768px) {
            .progress-sidebar {
                transform: translateX(-100%);
            }

            .progress-sidebar.open {
                transform: translateX(0);
            }

            .content {
                margin-left: 0;
            }

            header h1 {
                font-size: 1.8rem;
            }

            .card-content {
                padding: 1rem;
            }

            .table-container {
                font-size: 0.9rem;
            }
        }

        /* Scroll Progress Indicator */
        .scroll-progress {
            position: fixed;
            top: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: rgba(0,0,0,0.1);
            z-index: 2000;
        }

        .scroll-progress-bar {
            height: 100%;
            background: linear-gradient(to right, #1976d2, #7b1fa2, #388e3c);
            transition: width 0.2s ease;
            width: 0%;
        }
    </style>
</head>
<body>
    <div class="scroll-progress">
        <div class="scroll-progress-bar" id="scrollBar"></div>
    </div>

    <div class="container">
        <aside class="progress-sidebar" id="progressSidebar">
            <div class="progress-line"></div>
            <h3>Algorithm Progress</h3>
            <div class="progress-item active" data-card="assessment">
                <div class="progress-icon">üìã</div>
                <span>Assessment</span>
            </div>
            <div class="progress-item" data-card="diagnosis">
                <div class="progress-icon">üî¨</div>
                <span>Diagnosis</span>
            </div>
            <div class="progress-item" data-card="treatment">
                <div class="progress-icon">üíä</div>
                <span>Treatment</span>
            </div>
            <div class="progress-item" data-card="followup">
                <div class="progress-icon">üìà</div>
                <span>Follow-up</span>
            </div>
        </aside>

        <main class="content">
            <header>
                <h1>Progressive Supranuclear Palsy</h1>
                <p>Interactive Clinical Management Algorithm | BMJ Best Practice May 2024</p>
            </header>

            <!-- Assessment Card -->
            <div class="card assessment-card" id="assessment-card">
                <div class="card-header" onclick="toggleCard('assessment')">
                    <div class="card-title">
                        <div class="card-icon">üìã</div>
                        Assessment
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-body">
                    <div class="card-content">
                        <div class="section">
                            <h3>Key Diagnostic Features <span class="badge badge-urgent">High Priority</span></h3>
                            <ul>
                                <li>Postural instability with unexplained falls (often backwards) within first 3 years</li>
                                <li>Slow vertical saccades or vertical supranuclear gaze palsy</li>
                                <li>Axial-predominant akinetic-rigid parkinsonism with poor levodopa response</li>
                                <li>Early dysphagia and/or dysarthria</li>
                                <li>Frontal executive dysfunction (apathy, impulsivity)</li>
                            </ul>
                        </div>

                        <div class="section">
                            <h3>Physical Examination Checklist</h3>
                            <div class="info-grid">
                                <div class="info-item">
                                    <h4>Eye Movements</h4>
                                    <p>Test vertical saccades (slow, "round-the-houses" sign), doll's head maneuver, square wave jerks, optokinetic nystagmus</p>
                                </div>
                                <div class="info-item">
                                    <h4>Postural Instability</h4>
                                    <p>Perform pull test, observe gait (wide-based, en bloc turning), sit-to-stand assessment</p>
                                </div>
                                <div class="info-item">
                                    <h4>Cognitive Assessment</h4>
                                    <p>Use MoCA (preferred), evaluate executive function, verbal fluency, apathy scale</p>
                                </div>
                                <div class="info-item">
                                    <h4>Speech & Swallowing</h4>
                                    <p>Assess dysarthria, apraxia of speech, water swallow test for dysphagia</p>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <h3>Initial Investigations <span class="badge badge-caution">Essential</span></h3>
                            <div class="table-container">
                                <table>
                                    <thead>
                                        <tr>
                                            <th>Investigation</th>
                                            <th>Purpose/Findings</th>
                                            <th>Priority</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td>Brain MRI</td>
                                            <td>Midbrain atrophy ("hummingbird", "Mickey Mouse" signs), rule out other pathologies</td>
                                            <td><span class="badge badge-urgent">Critical</span></td>
                                        </tr>
                                        <tr>
                                            <td>Levodopa Trial</td>
                                            <td>Minimal/no response supports PSP diagnosis (‚â§30% improvement on MDS-UPDRS)</td>
                                            <td><span class="badge badge-caution">High</span></td>
                                        </tr>
                                        <tr>
                                            <td>FDG-PET</td>
                                            <td>Hypometabolism in medial frontal gyrus, anterior cingulate, pons, ventral striatum</td>
                                            <td><span class="badge badge-stable">Optional</span></td>
                                        </tr>
                                        <tr>
                                            <td>Polysomnography</td>
                                            <td>REM sleep behavior disorder uncommon (favors PD/DLB/MSA)</td>
                                            <td><span class="badge badge-stable">Selective</span></td>
                                        </tr>
                                        <tr>
                                            <td>Active Stand Test</td>
                                            <td>Distinguish from MSA/DLB (orthostatic hypotension absent in PSP)</td>
                                            <td><span class="badge badge-caution">Recommended</span></td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>

                        <div class="warning-box">
                            <strong>üö® Red Flags for Urgent Referral:</strong> Rapid symptom progression, frequent falls with injury, severe dysphagia with aspiration risk, profound executive dysfunction affecting safety
                        </div>
                    </div>
                </div>
            </div>

            <!-- Diagnosis Card -->
            <div class="card diagnosis-card" id="diagnosis-card">
                <div class="card-header" onclick="toggleCard('diagnosis')">
                    <div class="card-title">
                        <div class="card-icon">üî¨</div>
                        Diagnosis
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-body">
                    <div class="card-content">
                        <div class="section">
                            <h3>MDS-PSP Diagnostic Criteria (2017) <span class="badge badge-urgent">Gold Standard</span></h3>
                            <div class="highlight-box">
                                <strong>Mandatory Inclusion:</strong> Age ‚â•40 years, gradual progression, sporadic occurrence
                            </div>
                            
                            <h4>Four Functional Domains:</h4>
                            <div class="info-grid">
                                <div class="info-item">
                                    <h4>Ocular Motor</h4>
                                    <p><strong>O1:</strong> Vertical supranuclear gaze palsy<br>
                                    <strong>O2:</strong> Slow vertical saccades<br>
                                    <strong>O3:</strong> Macro square wave jerks/eyelid-opening apraxia</p>
                                </div>
                                <div class="info-item">
                                    <h4>Postural Instability</h4>
                                    <p><strong>P1:</strong> Repeated unprovoked falls within 3 years<br>
                                    <strong>P2:</strong> Falls on pull-test within 3 years<br>
                                    <strong>P3:</strong> >2 steps backward on pull-test</p>
                                </div>
                                <div class="info-item">
                                    <h4>Akinesia</h4>
                                    <p><strong>A1:</strong> Progressive gait freezing within 3 years<br>
                                    <strong>A2:</strong> Axial-predominant, levodopa-resistant parkinsonism<br>
                                    <strong>A3:</strong> Parkinsonism with tremor/asymmetry/levodopa-responsive</p>
                                </div>
                                <div class="info-item">
                                    <h4>Cognitive Dysfunction</h4>
                                    <p><strong>C1:</strong> Speech/language disorder (non-fluent aphasia/apraxia)<br>
                                    <strong>C2:</strong> Frontal behavioral presentation<br>
                                    <strong>C3:</strong> Corticobasal syndrome</p>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <h3>Diagnostic Certainty Levels</h3>
                            <div class="table-container">
                                <table>
                                    <thead>
                                        <tr>
                                            <th>Certainty Level</th>
                                            <th>Criteria Combinations</th>
                                            <th>Typical Phenotype</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><span class="badge badge-urgent">Probable PSP</span></td>
                                            <td>(O1 or O2) + (P1 or P2) [RS]<br>(O1 or O2) + A1 [PGF]<br>(O1 or O2) + (A2 or A3) [P]<br>(O1 or O2) + C2 [F]</td>
                                            <td>PSP-RS, PSP-PGF, PSP-P, PSP-F</td>
                                        </tr>
                                        <tr>
                                            <td><span class="badge badge-caution">Possible PSP</span></td>
                                            <td>O1 alone [OM]<br>O2 + P3 [RS]<br>A1 alone [PGF]<br>(O1 or O2) + C1 [SL]<br>(O1 or O2) + C3 [CBS]</td>
                                            <td>PSP-OM, PSP-RS, PSP-PGF, PSP-SL, PSP-CBS</td>
                                        </tr>
                                        <tr>
                                            <td><span class="badge badge-stable">Suggestive PSP</span></td>
                                            <td>O2 or O3 alone [OM]<br>P1 or P2 alone [PI]<br>O3 + (P2 or P3) [RS]<br>(A2 or A3) + any clue [P]<br>C1 or C3 alone [SL/CBS]</td>
                                            <td>Early/intermediate phenotypes</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>

                        <div class="section">
                            <h3>Key Differential Diagnoses</h3>
                            <ul>
                                <li><strong>Idiopathic Parkinson's Disease:</strong> Excellent levodopa response, limb-predominant symptoms, hyposmia common</li>
                                <li><strong>Multiple System Atrophy:</strong> Early autonomic dysfunction (orthostatic hypotension, severe urinary symptoms), cerebellar atrophy</li>
                                <li><strong>Dementia with Lewy Bodies:</strong> Visual hallucinations, fluctuating cognition, REM sleep behavior disorder</li>
                                <li><strong>Corticobasal Degeneration:</strong> Asymmetric limb dystonia, alien limb, myoclonus, cortical sensory loss</li>
                                <li><strong>Vascular Parkinsonism:</strong> Stepwise progression, lower-body parkinsonism, MRI infarcts</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Treatment Card -->
            <div class="card treatment-card" id="treatment-card">
                <div class="card-header" onclick="toggleCard('treatment')">
                    <div class="card-title">
                        <div class="card-icon">üíä</div>
                        Treatment
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-body">
                    <div class="card-content">
                        <div class="section">
                            <h3>Multidisciplinary Team Approach <span class="badge badge-urgent">Essential</span></h3>
                            <div class="highlight-box">
                                Core Team: Movement disorder neurologist, physiotherapist, occupational therapist, speech-language pathologist, social worker/case manager, neuropsychologist
                            </div>
                            <p>Goals: Symptomatic management, rehabilitation, fall prevention, optimize quality of life, advance care planning</p>
                        </div>

                        <div class="section">
                            <h3>Symptom-Specific Management Algorithm</h3>
                            
                            <h4>1. Parkinsonism <span class="badge badge-caution">Levodopa Trial Required</span></h4>
                            <ul>
                                <li><strong>Carbidopa/Levodopa:</strong> 25/100 mg TID, titrate to max 2000 mg/day levodopa over 4 weeks</li>
                                <li>Maintain minimum 1-3 months before assessing response (‚â§30% improvement defines resistance)</li>
                                <li>If no benefit, taper over 2 weeks and discontinue</li>
                                <li>Avoid dopamine agonists, MAO-B inhibitors, COMT inhibitors, anticholinergics</li>
                            </ul>

                            <h4>2. Gait & Balance Impairment <span class="badge badge-urgent">Fall Prevention Priority</span></h4>
                            <ul>
                                <li><strong>Daily physiotherapy:</strong> Resistance training, balance exercises, gait training (60-80 min/day, 5 days/week)</li>
                                <li><strong>Assistive devices:</strong> Weighted, wide-based walker with reverse brakes (U-Step¬Æ)</li>
                                <li>Visual/auditory cueing for freezing of gait</li>
                                <li>Trial amantadine 100-300 mg/day (weak evidence, monitor for psychosis)</li>
                                <li>CoQ10 trial for 2 months (minimal evidence, low risk)</li>
                            </ul>

                            <h4>3. Dysphagia & Drooling <span class="badge badge-urgent">Aspiration Risk</span></h4>
                            <ul>
                                <li><strong>SLP evaluation:</strong> Modified barium swallow if silent aspiration suspected</li>
                                <li>Postural maneuvers (chin-tuck), thickened liquids, soft/pureed foods</li>
                                <li>Consider Lee Silverman Voice Treatment (LSVT)</li>
                                <li><strong>PEG tube:</strong> If aspiration all textures + weight loss >10% or pneumonia</li>
                                <li><strong>Drooling:</strong> Glycopyrronium (no CNS penetration) or botulinum toxin (risk of worsening dysphagia)</li>
                            </ul>

                            <h4>4. Speech Impairment <span class="badge badge-stable">Rehabilitation Focus</span></h4>
                            <ul>
                                <li>Speech therapy for dysarthria/apraxia</li>
                                <li>LSVT may improve voice quality</li>
                                <li>Augmentative communication devices (alphabet board, eye-gaze systems)</li>
                                <li>Pacing techniques for palilalia</li>
                            </ul>

                            <h4>5. Behavioral Symptoms <span class="badge badge-caution">Caution with Medications</span></h4>
                            <ul>
                                <li><strong>Depression:</strong> SSRI (citalopram, escitalopram, sertraline) - avoid TCAs</li>
                                <li><strong>Emotional lability/PBA:</strong> Dextromethorphan/quinidine (most effective), SSRIs as alternative</li>
                                <li><strong>Impulsivity:</strong> Reduce/stop dopaminergics, trial non-dopaminergic SSRIs</li>
                                <li>Apathy: Generally pharmacoresistant, focus on behavioral strategies</li>
                            </ul>

                            <h4>6. Cognitive Impairment <span class="badge badge-caution">Limited Options</span></h4>
                            <ul>
                                <li>NO proven symptomatic therapy for executive dysfunction</li>
                                <li>If Alzheimer's-type memory impairment predominates: cautious trial of donepezil (worsens mobility)</li>
                                <li>Avoid memantine (may worsen cognition)</li>
                                <li>Occupational therapy: structured routines, daily planners, environmental modifications</li>
                            </ul>

                            <h4>7. Dystonia <span class="badge badge-stable">Botulinum Toxin</span></h4>
                            <ul>
                                <li><strong>Botulinum toxin injection:</strong> Limb, cervical, facial (blepharospasm) dystonia - repeat q3 months</li>
                                <li>Avoid anticholinergics (cognitive impairment)</li>
                                <li>Muscle relaxants (baclofen, clonazepam) only as last resort</li>
                                <li>Eyelid-opening apraxia: neuro-ophthalmology referral</li>
                            </ul>

                            <h4>8. Sleep Disturbance <span class="badge badge-stable">Standard Approaches</span></h4>
                            <ul>
                                <li><strong>Insomnia:</strong> Melatonin (also for REM behavior disorder)</li>
                                <li><strong>Daytime sleepiness:</strong> Modafinil/armodafinil 200-400 mg, methylphenidate 10-60 mg/day</li>
                                <li><strong>‚ö†Ô∏è AVOID benzodiazepines</strong> - associated with faster PSP progression</li>
                                <li>OBSTRUCTIVE SLEEP APNEA: CPAP, positioning, weight loss</li>
                            </ul>

                            <h4>9. Constipation <span class="badge badge-stable">Standard Management</span></h4>
                            <ul>
                                <li>Non-pharmacological: Hydration, fiber, physical activity</li>
                                <li>Docusate stool softener, osmotic laxatives (PEG, magnesium citrate)</li>
                                <li>Avoid stimulant laxatives long-term</li>
                            </ul>

                            <h4>10. Urinary Symptoms <span class="badge badge-stable">Urology Input</span></h4>
                            <ul>
                                <li><strong>Obstruction:</strong> Alpha-blockers (terazosin, doxazosin, tamsulosin)</li>
                                <li><strong>Overactive bladder:</strong> Beta-3 agonist (mirabegron)</li>
                                <li>Avoid antimuscarinics (cognitive effects)</li>
                            </ul>
                        </div>

                        <div class="warning-box">
                            <strong>‚ö†Ô∏è Critical Safety Alerts:</strong><br>
                            ‚Ä¢ Benzodiazepines accelerate PSP progression - AVOID<br>
                            ‚Ä¢ Anticholinergics worsen cognition - minimize CNS penetration<br>
                    ‚Ä¢ Polypharmacy common - regularly review and discontinue ineffective medications
                        </div>
                    </div>
                </div>
            </div>

            <!-- Follow-up Card -->
            <div class="card followup-card" id="followup-card">
                <div class="card-header" onclick="toggleCard('followup')">
                    <div class="card-title">
                        <div class="card-icon">üìà</div>
                        Follow-up
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-body">
                    <div class="card-content">
                        <div class="section">
                            <h3>Prognosis & Disease Monitoring <span class="badge badge-urgent">Poor Prognosis</span></h3>
                            <div class="info-grid">
                                <div class="info-item">
                                    <h4>PSP-RS (Classic)</h4>
                                    <p>Median survival: <strong>6-8 years</strong> from symptom onset<br>
                                    Median survival: <strong>5.3 years</strong> from diagnosis<br>
                                    Rapid progression: wheelchair <3 years, severe dysphagia <4 years</p>
                                </div>
                                <div class="info-item">
                                    <h4>PSP-P (Parkinsonism)</h4>
                                    <p>Mean survival: <strong>11.2 years</strong><br>
                                    Slower progression, better levodopa response initially</p>
                                </div>
                                <div class="info-item">
                                    <h4>PSP-PGF (Gait Freezing)</h4>
                                    <p>Mean survival: <strong>11.5 years</strong><br>
                                    Can survive up to 19 years</p>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <h3>Poor Prognostic Factors <span class="badge badge-urgent">Early Palliative Care Trigger</span></h3>
                            <ul>
                                <li>Early falls (within first year)</li>
                                <li>Early cognitive impairment/dementia</li>
                                <li>Early dysphagia (within 2 years)</li>
                                <li>PSP-RS phenotype</li>
                                <li>Older age at onset</li>
                                <li>Rapid symptom progression</li>
                            </ul>
                        </div>

                        <div class="section">
                            <h3>Monitoring Tools</h3>
                            <ul>
                                <li><strong>PSP Rating Scale (PSPRS):</strong> Recommended by ERN-RND to track progression</li>
                                <li><strong>Clinical milestones:</strong> Walking aid requirement, wheelchair dependence, severe dysphagia, cognitive decline, recurrent falls</li>
                                <li><strong>Cognitive monitoring:</strong> MoCA every 6-12 months, neuropsychological evaluation if declining</li>
                                <li><strong>Functional assessment:</strong> ADLs, swallowing function, speech intelligibility</li>
                            </ul>
                        </div>

                        <div class="section">
                            <h3>Palliative Care & Advance Planning <span class="badge badge-urgent">Start Within 1st Year</span></h3>
                            <ul>
                                <li><strong>Initiate discussions at diagnosis:</strong> Disease trajectory, prognosis, goals of care</li>
                                <li><strong>Advance directives:</strong> Decision-making capacity may decline within 2-3 years</li>
                                <li><strong>Feeding decisions:</strong> PEG timing, aspiration risk management</li>
                                <li><strong>End-of-life planning:</strong> Preferred place of care, resuscitation status</li>
                                <li><strong>Support services:</strong> PSP Association (UK), CurePSP (US), caregiver respite</li>
                            </ul>
                        </div>

                        <div class="section">
                            <h3>Caregiver Support & Resources</h3>
                            <div class="info-grid">
                                <div class="info-item">
                                    <h4>Educational Resources</h4>
                                    <p>‚Ä¢ PSP Association (UK): www.pspassociation.org.uk<br>
                                    ‚Ä¢ CurePSP (US): www.psp.org<br>
                                    ‚Ä¢ Association for Frontotemporal Degeneration: www.theaftd.org</p>
                                </div>
                                <div class="info-item">
                                    <h4>Caregiver Burden</h4>
                                    <p>High rates of depression, anxiety, burden - routine screening recommended<br>
                                    Respite care essential</p>
                                </div>
                            </div>
                        </div>

                        <div class="highlight-box">
                            <strong>üîç Key Follow-up Actions:</strong><br>
                            ‚Ä¢ Review every 3-6 months initially, then 6-12 months<br>
                            ‚Ä¢ Monitor for medication side effects and polypharmacy<br>
                            ‚Ä¢ Assess fall risk and home safety at each visit<br>
                            ‚Ä¢ Screen for depression in both patient and caregiver<br>
                            ‚Ä¢ Reassess need for therapy services regularly
                        </div>
                    </div>
                </div>
            </div>

            <footer style="text-align: center; padding: 2rem; color: #6c757d; font-size: 0.9rem;">
                <p>Based on BMJ Best Practice Guidelines | Last Updated: May 2024</p>
                <p>Designed for educational purposes - clinical judgment should always be applied</p>
            </footer>
        </main>
    </div>

    <script>
        // Card toggle functionality
        function toggleCard(cardId) {
            const card = document.getElementById(cardId + '-card');
            const isExpanded = card.classList.contains('expanded');
            
            // Close all cards
            document.querySelectorAll('.card').forEach(c => c.classList.remove('expanded'));
            
            // Toggle clicked card
            if (!isExpanded) {
                card.classList.add('expanded');
            }
            
            // Update progress sidebar
            updateProgressSidebar(cardId);
        }

        // Progress sidebar functionality
        function updateProgressSidebar(activeCard) {
            const progressItems = document.querySelectorAll('.progress-item');
            progressItems.forEach(item => {
                item.classList.remove('active');
                if (item.dataset.card === activeCard) {
                    item.classList.add('active');
                }
            });
        }

        // Progress sidebar click navigation
        document.querySelectorAll('.progress-item').forEach(item => {
            item.addEventListener('click', () => {
                const cardId = item.dataset.card;
                const card = document.getElementById(cardId + '-card');
                
                // Scroll to card
                card.scrollIntoView({ behavior: 'smooth', block: 'start' });
                
                // Expand card
                document.querySelectorAll('.card').forEach(c => c.classList.remove('expanded'));
                card.classList.add('expanded');
                
                // Update progress
                updateProgressSidebar(cardId);
            });
        });

        // Scroll progress bar
        function updateScrollProgress() {
            const scrollBar = document.getElementById('scrollBar');
            const scrollTop = window.pageYOffset;
            const docHeight = document.body.scrollHeight - window.innerHeight;
            const scrollPercent = (scrollTop / docHeight) * 100;
            scrollBar.style.width = scrollPercent + '%';
        }

        // Intersection Observer for progress sidebar
        const observerOptions = {
            root: null,
            rootMargin: '-20% 0px -70% 0px',
            threshold: 0
        };

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    const cardId = entry.target.id.replace('-card', '');
                    updateProgressSidebar(cardId);
                }
            });
        }, observerOptions);

        // Observe all cards
        document.querySelectorAll('.card').forEach(card => {
            observer.observe(card);
        });

        // Smooth scroll for better UX
        document.addEventListener('scroll', () => {
            updateScrollProgress();
        });

        // Initialize: expand assessment card by default
        window.addEventListener('load', () => {
            document.getElementById('assessment-card').classList.add('expanded');
            updateProgressSidebar('assessment');
        });

        // Mobile sidebar toggle (for responsive)
        const sidebar = document.getElementById('progressSidebar');
        let touchStartX = 0;
        let touchEndX = 0;

        document.addEventListener('touchstart', e => {
            touchStartX = e.changedTouches[0].screenX;
        });

        document.addEventListener('touchend', e => {
            touchEndX = e.changedTouches[0].screenX;
            handleSwipe();
        });

        function handleSwipe() {
            if (window.innerWidth <= 768) {
                if (touchEndX < touchStartX - 50) {
                    sidebar.classList.remove('open');
                }
                if (touchEndX > touchStartX + 50 && touchStartX < 50) {
                    sidebar.classList.add('open');
                }
            }
        }
    </script>
</body>
</html>